|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1993-4-6
|
|
pubmed:abstractText |
To compare the effect on toxicity and efficacy of the fluorouracil 500 mg/m2, epirubicin 60 mg/m2, and cyclophosphamide 500 mg/m2 (FEC) regimen divided into 4 weekly doses with conventional every-4-week administration in metastatic breast cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
467-73
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8445422-Adult,
pubmed-meshheading:8445422-Aged,
pubmed-meshheading:8445422-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8445422-Breast Neoplasms,
pubmed-meshheading:8445422-Cyclophosphamide,
pubmed-meshheading:8445422-Drug Administration Schedule,
pubmed-meshheading:8445422-Epirubicin,
pubmed-meshheading:8445422-Female,
pubmed-meshheading:8445422-Fluorouracil,
pubmed-meshheading:8445422-Humans,
pubmed-meshheading:8445422-Middle Aged,
pubmed-meshheading:8445422-Neoplasm Metastasis,
pubmed-meshheading:8445422-Survival Analysis,
pubmed-meshheading:8445422-Treatment Outcome
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Influence of treatment schedule on toxicity and efficacy of cyclophosphamide, epirubicin, and fluorouracil in metastatic breast cancer: a randomized trial comparing weekly and every-4-week administration.
|
|
pubmed:affiliation |
Department of Radiotherapy, University of Helsinki, Finland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
